<--- Back to Details
First PageDocument Content
Medicine / Nanomaterials / Anthracyclines / Doxorubicin / Alternative complement pathway / IC3b / Immunoassay / Complement component 3 / Nanoparticle / Complement system / Immunologic tests / Biology
Date: 2011-09-26 14:00:18
Medicine
Nanomaterials
Anthracyclines
Doxorubicin
Alternative complement pathway
IC3b
Immunoassay
Complement component 3
Nanoparticle
Complement system
Immunologic tests
Biology

Microsoft Word - NCL_Method_ITA-5.2_RMC edit.doc

Add to Reading List

Source URL: ncl.cancer.gov

Download Document from Source Website

File Size: 77,71 KB

Share Document on Facebook

Similar Documents

Ribbon symbolism / RTT / Anthracyclines / Epirubicin / Docetaxel / Survival rate / CMF / TOP2A / Breast cancer

DBCG-07 Forkortelser, Bilag 1 Forkortelse

DocID: 1pq5O - View Document

Ribbon symbolism / Anthracyclines / Epirubicin / CMF / Survival rate / Breast cancer / TOP2A

DBCG 07-REAL Forkortelser, Bilag 1 DANISH BREAST CANCER COOPERATIVE GROUP

DocID: 1oFQM - View Document

Membrane biology / Daunorubicin / SanDisk / Biology / Pharmacology / Anthracyclines / Medicine / Liposome

AIA, Business, Practice, and Beyond This is MoFo. 1

DocID: 16omP - View Document

Membrane biology / Daunorubicin / SanDisk / Biology / Pharmacology / Anthracyclines / Medicine / Liposome

AIA, Business, Practice, and Beyond This is MoFo. 1

DocID: 165vb - View Document

Myocet / Doxorubicin / Liposome / Chemotherapy-induced acral erythema / Liposomal daunorubicin / Amphotericin B / PEGylation / Daunorubicin / Epirubicin / Medicine / Anthracyclines / Oncology

Ratio of involved/uninvolved immunoglobulin quantification by Hevylite™ assay: clinical and prognostic impact in multiple myeloma

DocID: 15Ylu - View Document